Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer
(PCa) cells, and several PSMA ligands for PET imaging are now available worldwide. 68Ga …
(PCa) cells, and several PSMA ligands for PET imaging are now available worldwide. 68Ga …
PSMA PET in imaging prostate cancer
I Tsechelidis, A Vrachimis - Frontiers in oncology, 2022 - frontiersin.org
After prostate malignancy diagnosis, precise determination of disease extent are
fundamental steps for tailored made therapy. The earlier the diagnosis of the burden of the …
fundamental steps for tailored made therapy. The earlier the diagnosis of the burden of the …
E-PSMA: the EANM standardized reporting guidelines v1. 0 for PSMA-PET
Rationale The development of consensus guidelines for interpretation of Prostate-Specific
Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide …
Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide …
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective …
Summary Background Lutetium-177 (177 Lu) prostate-specific membrane antigen (177 Lu-
PSMA) is a novel targeted treatment for patients with metastatic castration-resistant prostate …
PSMA) is a novel targeted treatment for patients with metastatic castration-resistant prostate …
Using PSMA imaging for prognostication in localized and advanced prostate cancer
MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …
prostate cancer management has evolved rapidly over the past few years, helping to …
Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis
Purpose Many radiotracers are currently available for the detection of recurrent prostate
cancer (rPC), yet many have not been compared head-to-head in comparative imaging …
cancer (rPC), yet many have not been compared head-to-head in comparative imaging …
[HTML][HTML] [68Ga] Ga-PSMA-11 in prostate cancer: a comprehensive review
Imaging of the prostate-specific membrane antigen (PSMA) has become an important tool
for managing patients with recurrent prostate cancer, and one of the most frequently …
for managing patients with recurrent prostate cancer, and one of the most frequently …
Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy—a multi-centre evaluation of 2533 patients
A Afshar-Oromieh, ML da Cunha, J Wagner… - European journal of …, 2021 - Springer
Purpose To evaluate the performance of [68 Ga] Ga-PSMA-11 PET/CT in the diagnosis of
recurrent prostate cancer (PC) after prostatectomy in a large multicentre cohort. Methods …
recurrent prostate cancer (PC) after prostatectomy in a large multicentre cohort. Methods …
PSMA-PET guided treatment in prostate cancer patients with oligorecurrent progression after previous salvage treatment
L Bianchi, F Ceci, E Balestrazzi, F Costa, M Droghetti… - Cancers, 2023 - mdpi.com
Simple Summary Prostate Specific Membrane Antigen-Positron Emission Tomography
(PSMA-PET) is currently recommended to stage Prostate Cancer (PCa) patients with …
(PSMA-PET) is currently recommended to stage Prostate Cancer (PCa) patients with …
[HTML][HTML] Metastatic sites' Location and impact on patient management after the introduction of prostate-specific membrane antigen positron emission tomography in …
Context The introduction of prostate-specific membrane antigen positron emission
tomography (PSMA-PET) had a substantial impact on the management of prostate cancer …
tomography (PSMA-PET) had a substantial impact on the management of prostate cancer …